KELSEY FRYBERGER: Open Payments
NPI 1770016552 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,408 in 70 payments from 20 companies in 2025. Trend: 2023 $1,838 · 2024 $1,863 · 2025 $1,408
Food & beverage: $1,408
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $273 |
| ABBVIE INC. | 8 | $146 |
| Novo Nordisk Inc | 7 | $121 |
| Lilly USA, LLC | 6 | $112 |
| PFIZER INC. | 5 | $101 |
| Astellas Pharma US Inc | 4 | $93 |
| SANOFI-AVENTIS U.S. LLC | 4 | $90 |
| GlaxoSmithKline, LLC. | 6 | $86 |
| Amgen Inc. | 5 | $72 |
| Novartis Pharmaceuticals Corporation | 3 | $58 |
Products named: AIRSUPRA, QULIPTA, TZIELD, JARDIANCE, Veozah, TRELEGY ELLIPTA, MOUNJARO, LEQVIO.
Industry payments across DE — which companies pay providers there.
